Parallax Volatility Advisers, L.P. Jounce Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$4.3 - $6.73 $43,860 - $68,646	-10,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.43 - $6.87 $34,986 - $70,074	10,200 New	10,200 $63,000
Q4 2018 Feb 14, 2019	SELL	$2.69 - $6.71 $16,360 - $40,810	-6,082 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.5 - $8.37 $39,533 - $50,906	6,082 New	6,082 $40,000
Q1 2018 May 15, 2018	SELL	$13.4 - $28.4 $29,265 - $62,025	-2,184 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.52 - $17.82 $27,343 - $38,918	2,184	2,184 $28,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.